New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics


October 2017

Welcome to the October 2017 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the October issue!

The PharmSource Team

Up and Away, M&A

by Jim Miller, Founder and President

Mergers and acquisitions are positive for the CDMO industry, but there is a downside. Mergers and acquisitions (M&A) are a central feature of the contract development and manufacturing (CDMO) industry today. Several new deals are being announced every month, some of them quite substantial, and these deals are reshaping the industry. CDMOs are in great…read on

PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity


Lead Type July 2017 YTD 2017
Early Development 115 1009
Late Development 98 977
Biologic 120 934
Small Molecule 145 2115
Parenteral 139 996
Oral 98 878
New Financings 180 836
Total Drug Leads 405 3343
Total Device &
Diagnostic Leads
115 1220

*Total leads include acquisitions/alliances, company acquisition/alliances and events.

Pipeline Tip

ACADIA initiates the Phase III HARMONY study with NUPLAZID for the treatment of hallucinations and delusions associated with dementia-related psychosis:

  • Therapeutic Area: Antipsychotic & Alzheimer’s disease/Dementia
  • Dosage Form: Tablet
  • API: Chemical – Normal potency

Get deeper information about the likely upcoming needs of Rebiotix, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.

Follow the Money to

Bio/Pharmaceutical Opportunities

Spotlight on Fusion Pharmaceuticals, Inc.

ARMO BioSciences is a US private company that develops immunotherapies for the treatment of cancer, cardiovascular diseases, fibrosis and inflammation. It raised $67 million in a venture capital investment.

Fusion Pharmaceuticals is a private company based in Canada that develops radiotherapeutics for the treatment of cancer. It raised $21 million in a venture capital investment…. read on

Follow the Money to

Medical Device & Diagnostic Opportunities

Spotlight on Cambridge Medical Robotics Ltd.

Cambridge Medical Robotics is a private company based in the UK that develops next-generation robotic systems for minimal access surgery. It raised $26 million in the completion of a venture capital investment.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support the R&D efforts for its Versius surgical robotic system… read on

Dose CMOs Stuck in Idle

PharmSource’s just-released trend report, Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook – 2017 Edition, reveals several factors for the dose CMO industry’s relatively poor performance in 2016:

1. Rebound in drug development since 2013 is too recent to benefit dose CMOs

2. Heavy investment in captive capacity by global bio/pharma companies

3. Declining significance of dose manufacturing in drug cost of goods as new drugs with high value APIs dominate the pipeline


Jim Miller is speaking

Jim Miller will be speaking in Frankfurt, Germany on the 23rd of October at the CPhI Pre-Connect Conference on trends in the contract manufacturing industry.

He will also be speaking in San Diego, CA on the 13th of November at the AAPS Annual Meeting on trends in the contract manufacturing industry.

PharmSource Lead Sheet

The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

See for yourself how this resource can be a vital tool for building your brand and growing your market share.

To request a test-drive today, contact Nathaniel Celentano at / 1-703-383-4903, ext. 112 (ET USA).